Innovation Health and Wealth introduced a NICE Compliance Regime for technology appraisals. The aim is to support patient access to NICE approved medicines and technologies.
Formularies have an important role in underpinning safe and effective use of medicines. They should not duplicate NICE assessments or challenge an appraisal recommendation. Once on formularies, there should be no further barriers to the use or prescription of technologies or medicines.
David Nicholson has written to strategic health authorities, primary care trusts (PCTs), clinical commissioning groups (CCGs) leaders wanting to see all NHS organisations publish information, which sets out which NICE technology appraisals are included in their local formularies. PCT clusters and CCGs will need to take the lead in working towards publication by 1 April 2013 and the intention is to make this a standard term and condition in NHS contracts.